Investor Relations

Charles River Associates (CRA) Announces Vice President Promotions

04/03/18

BOSTON--(BUSINESS WIRE)--Apr. 3, 2018-- Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that Tiago Duarte-Silva, in the Finance Practice, Angela De Martini, Lev Gerlovin, Aileen Nicoletti, and Ryan Tubman, in the Life Sciences Practice, and Oliver Latham, in the Antitrust & Competition Economics Practice have been promoted to the role of vice president.

“It is a pleasure to recognize these individuals on their promotions to vice president,” said CRA’s President and Chief Executive Officer Paul Maleh. “Their drive and commitment to building their expertise and being trusted advisors to their clients and colleagues represent the attributes we seek in leaders of the firm. We are proud of their many contributions and congratulate them on this career milestone.”

Angela De Martini specializes in pharmaceuticals and medical devices. She serves clients across a wide range of functions, including business insights and analytics, marketing, medical affairs, and market access. She was previously a director at C1 Consulting.

Tiago Duarte-Silva specializes in damages and securities disputes. As a testifying expert, Dr. Duarte-Silva has provided expert opinions and testified at trial and deposition both in domestic and international arbitration and litigation as well as before the US Department of Commerce. He also has several years of industry experience valuing companies in developed and emerging markets. Dr. Duarte-Silva is an adjunct professor at Boston College, where he teaches valuation.

Lev Gerlovin has been a key contributor to the growth of the Life Sciences Practice at CRA over the past 11 years. He has built a reputation for putting client needs first and collaborating across the firm to build a strong, multi-disciplinary offering. Lev is seen internally as a mentor and team-builder and involved in recruiting, training, and other corporate citizenship initiatives. He co-leads the practice’s Pharma 2030 thought leadership initiative, focused on the future direction of the healthcare industry.

Oliver Latham has led multiple assignments for CRA. These include on the economics of platforms, where his work covers high-profile cases, including running the team and providing expert economic evidence for Visa Europe in the interchange fee litigation before the High Court, work related to search and data for NewsCorp and others, and developing economic evidence for Uber on multiple transactions. Outside of technology and platforms, he has worked on a number of high-profile conduct and merger cases.

Aileen Nicoletti has expertise in leveraging market research and data analytics to articulate product and portfolio value and inform clinical development and commercialization strategy. Dr. Nicoletti focuses on understanding key value drivers in the context of evolving clinical, commercial, and payer landscapes, and communicating compelling narratives across stakeholder groups. Dr. Nicoletti was previously a director at C1 Consulting and a vice president at Defined Health, where she led the Immunology and Ophthalmology Practices.

Ryan Tubman focuses on leveraging analytics and customer insights to develop evidence-based strategies for pharmaceutical and biotech organizations. His work spans early pipeline to in-line products, often involving patient-level claims, data-based analytics and modelling, market research, and forecasting. Mr. Tubman was previously a director at C1 Consulting and held multiple roles at Blue Ridge Partners.

About Charles River Associates (CRA)
Charles River Associates® is a global consulting firm specializing in economic, financial, and management consulting services. CRA advises clients on economic and financial matters pertaining to litigation and regulatory proceedings, and guides corporations through critical business strategy and performance-related issues. Since 1965, clients have engaged CRA for its unique combination of functional expertise and industry knowledge, and for its objective solutions to complex problems. Headquartered in Boston, CRA has offices throughout the world. Detailed information about Charles River Associates, a registered trade name of CRA International, Inc., is available at www.crai.com. Follow us on LinkedInTwitter, and Facebook.

Source: Charles River Associates

Media Relations
Charles River Associates, 617-425-6453
media@crai.com
or
Sharon Merrill Associates, Inc.
Andrew Blazier, 617-542-5300
Senior Associate